We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Newly Reengineered Line of Inverted Microscope Systems to Be Unveiled

By LabMedica International staff writers
Posted on 23 Jul 2012
A newly reengineered line of highly customizable inverted microscope systems will become available for biotech and life science researchers beginning in the fall of 2012.

The well-known microscope manufacturer Olympus (Hamburg, Germany) plans to unveil the new IX3 line of inverted research microscopes at the European Microscopy Congress (EMC) 2012, which is to be held in Manchester, United Kingdom from September 16-21. This event was selected as being especially appropriate, since EMC - which is held once every four years - is Europe's largest exhibition dedicated to microscopy.

Image: The IX3 line of inverted research microscopes (Photo courtesy of Olympus).
Image: The IX3 line of inverted research microscopes (Photo courtesy of Olympus).

Olympus states that the new IX3 systems will offer enhanced precision, stability, and optical performance to meet the most challenging quantitative measurement applications, along with user friendliness, speed, accuracy, and rugged reliability. The company will be hosting several breakout workshops at EMC 2012, where Olympus’ experts will discuss the range of applications offered by the new systems.

IX3 systems will be available for purchase in Europe starting from September 2012.

Related Links:
Olympus



Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Automated Blood Typing System
IH-500 NEXT
New
CVD Risk Test
GammaCoeur CVD Risk ELISA Test
New
Progesterone Serum Assay
Progesterone ELISA Kit

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma

New Method Simplifies Preparation of Tumor Genomic DNA Libraries